Barclays raised the firm’s price target on Estee Lauder to $146 from $141 and keeps an Equal Weight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EL:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Oppenheimer says investors not rushing in to buy amid Ulta downbeat commentary
- Ulta Beauty stock slides on âslower growth than anticipatedâ
- Estee Lauder upgraded, Petco downgraded: Wall Street’s top analyst calls
- Estee Lauder upgraded to Buy from Neutral at Citi